Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here for this GPCR stock update.

Chromosomes are masters of organization. These long strings of DNA fold down into an ensemble of compact structures that keep needed parts of the genome accessible while tucking away those that aren't ...

Autodesk Revit is the leading Building Information Modeling (BIM) solution for architects, engineers, and construction teams. It unites design, documentation, and collaboration in one intelligent ...

What would a Tesla be without controversy and split opinions? The Tesla Model Y’s midcycle refresh brought significant enough changes to earn it a spot in our 2026 SUV of the Year competition. The ...

This paper introduces the Israeli Structural Model (ISM), a New-Keynesian Dynamic Stochastic General Equilibrium (DSGE) model tailored to reflect key characteristics of the Israeli economy. The ISM ...

Tesla has finally introduced the long-awaited, cheaper versions of its Model Y and Model 3 cars. The new cars, which the company unveiled in an X post on Tuesday, Oct. 7, are the brand’s most ...

Pranam Chatterjee, PhD, assistant professor of bioengineering at the University of Pennsylvania (UPenn), emphasizes that text is all you need for artificial intelligence (AI) models to effectively ...

This New AI is 100x Faster at Reasoning Than ChatGPT Your email has been sent The tiny Hierarchical Reasoning Model mimics the brain’s structure to solve complex tasks in a single pass — no ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Even though it might seem like Tesla has a lot going on—robotaxis, literal humanoid robots, and that ever-elusive affordable model that just keeps getting pushed back—its aging core lineup has only ...

Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...